胎儿生长受限专家共识（2019版）

胎儿生长受限(fetal growth restriction,FGR)是导致围产儿患病和死亡的重要原因,还可能带来远期的不良结局。为规范和指导我国FGR的临床诊治工作,中华医学会围产医学分会胎儿医学学组联合中华医学会妇产科学分会产科学组,组织全国专家讨论并制定了我国FGR专家共识。本共识围绕FGR的定义、筛查、预防、诊断、宫内监护及临床处理等方面的临床问题,参考最新发表的各国FGR指南和高质量临床研究结果,运用德尔菲法,通过3轮专家意见调查及多学科专家的讨论,形成相对应的推荐及共识。

Fetal growth restriction(FGR)is associated with higher perinatal mortality and morbidity,as well as a variety of long-term adverse outcomes.To standardize the clinical practice for the management of FGR in China,Fetal Medicine Subgroup,Society of Perintal Medicine,Chinese Medical Association and Obstetrics Subgroup,Society of Obstetrics and Gynecology,Chinese Medical Association organized an expert committee to provide official consensus-based recommendations on FGR.The consensus was developed by experts'reviewing official guidelines from other countries,evaluating the results from relevant high quality literatures,performing a three-round Delphi study and organizing face-to-face meetings among experts with multidisciplinary backgrounds.Recommendations were presented regarding definition,screening,prevention,diagnosis,monitoring,and management of FGR.